The cancer-type level calculation of the population carrier rate of gene alterations among the NSCLC cohort shows that KRAS mutations are the most common somatic alterations in the Western population of the NSCLC (> 20%), while EGFR variations account for the largest proportion in the Chinese population (Fig. 3C). This evidence concerns the gene EGFR and cancer.